Research Coverage of Japanese Listed Companies, Shared Research Inc

Shared Research

Research Coverage of Japanese Listed Companies

Shared Research Inc

Pioneering research coverage of Japanese listed companies. Now customizable and interactive for global institutional investors. Corporate access reimagined.

Equity Bottom-Up

<ul><li>Operating revenue increased 79.6% YoY to JPY1.5bn, driven by strong sales of TDM-621 across multiple regions.</li><li>Operating loss narrowed to JPY317mn, with SG&A expenses rising 16.0% YoY to JPY1.2bn and R&D expenses up 1.7% YoY.</li><li>Recurring loss of JPY787mn, including foreign exchange losses of JPY449mn and interest expenses of JPY21mn.</li></ul>

Operating revenue increased 79.6% YoY to JPY1.5bn, driven by strong sales of TDM-621 across multiple regions.Operating loss narrowed to JPY317mn, with SG&A expenses rising 16.0% YoY to JPY1.2bn and R&D expenses up 1.7% YoY.Recurring loss of JPY787mn, including foreign exchange losses of JPY449mn and interest expenses of JPY21mn.

3 D Matrix Ltd (7777 JP): Q1 FY04/25 flash update

Japan

3-D Matrix, Ltd. researches and develops medical products by applying self assembling peptide technology.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

3 D Matrix Ltd (7777 JP): Q1 FY04/25 flash update

Operating revenue increased 79.6% YoY to JPY1.5bn, driven by strong sales of TDM-621 across multiple regions. Operating loss narrowed to JPY317mn,...

Shared Research